1. Home
  2. MITK vs CSTL Comparison

MITK vs CSTL Comparison

Compare MITK & CSTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Mitek Systems Inc.

MITK

Mitek Systems Inc.

N/A

Current Price

$18.92

Market Cap

723.9M

Sector

Technology

ML Signal

N/A

Logo Castle Biosciences Inc.

CSTL

Castle Biosciences Inc.

N/A

Current Price

$33.40

Market Cap

722.8M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
MITK
CSTL
Founded
1983
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Computer peripheral equipment
Medical Specialities
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
723.9M
722.8M
IPO Year
1995
2019

Fundamental Metrics

Financial Performance
Metric
MITK
CSTL
Price
$18.92
$33.40
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
6
Target Price
$15.00
$45.50
AVG Volume (30 Days)
704.2K
492.9K
Earning Date
05-07-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
171.43
N/A
EPS
0.43
N/A
Revenue
$45,390,000.00
$344,229,000.00
Revenue This Year
$9.55
$2.42
Revenue Next Year
$8.07
$12.69
P/E Ratio
$44.67
N/A
Revenue Growth
N/A
3.66
52 Week Low
$8.53
$17.72
52 Week High
$21.05
$44.28

Technical Indicators

Market Signals
Indicator
MITK
CSTL
Relative Strength Index (RSI) 54.10 63.27
Support Level $18.08 $22.88
Resistance Level $20.56 $33.75
Average True Range (ATR) 0.80 1.74
MACD 0.02 0.04
Stochastic Oscillator 63.75 75.93

Price Performance

Historical Comparison
MITK
CSTL

About MITK Mitek Systems Inc.

Mitek Systems Inc is engaged in the development, sale, and service of proprietary software solutions related to mobile imaging. The firm is a software development company with expertise in artificial intelligence, and machine learning. It serves more than 7,900 financial services organizations, financial technology (fintech) brands, telecommunications companies, and marketplace brands across the globe. The company's Mobile Deposit solution is used by consumers for mobile check deposits. The company's Mobile Verify verifies a user's identity online, enabling organizations to build safer digital communities, whereas CheckReader enables financial institutions to automatically extract data from a check image received across any deposit channel - branch, ATM, RDC, and mobile.

About CSTL Castle Biosciences Inc.

Castle Biosciences Inc is a molecular diagnostics company. The group provides test solutions for the diagnosis and treatment of dermatologic cancers, Barrett's esophagus (BE), and uveal melanoma. The product portfolio of the company includes DecisionDx-Melanoma, a risk stratification gene expression profile (GEP) test; DecisionDx-SCC, a risk stratification test for cutaneous squamous cell carcinoma; MyPath Melanoma, a diagnostic GEP test for use in patients with difficult-to-diagnose melanocytic lesions; and TissueCypher, a test to predict future development of progression of high-grade dysplasia and/or esophageal cancer. The company derives revenues through the delivery of test reports for its molecular diagnostic tests.

Share on Social Networks: